Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective

PURPOSE: To evaluate the cost-effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) vs twice-daily budesonide/formoterol (BUD/FOR) in patients with symptomatic chronic obstructive pulmonary disease (COPD) at risk of exacerbations, from the Spanish National Healthcare S...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Chron Obstruct Pulmon Dis
Main Authors: Schroeder, Melanie, Benjamin, Nicole, Atienza, Laura, Biswas, Chandroday, Martin, Alan, Whalen, John D, Izquierdo Alonso, José Luis, Riesco Miranda, Juan Antonio, Soler-Cataluña, Juan José, Huerta, Alicia, Ismaila, Afisi S
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7360413/
https://ncbi.nlm.nih.gov/pubmed/32764908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S240556
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker